Be part of the next STS Leadership Institute graduate class!
Event dates
Mar 21, 2024 – Jan 24, 2025
Location
Zoom, Chicago, and Los Angeles
How to manage an airway injury and other challenging cases
Date
7 p.m. E.T.
Demystify the Oral Board Exam with STS Prep
Event dates
Apr 16 – May 7, 2024
Location
Virtual
Hands-on team training in robotic mitral valve repair, coronary bypass, and more.
Event dates
May 9–10, 2024
Location
Peachtree Corners, GA

Hear about the invaluable benefits of becoming an active and involved member of STS, your career journey partner. Involvement opportunities to be discussed include joining a task force or workforce, becoming an advocate on healthcare policy, and developing new tools and resources to improve patient care.

Date
7 p.m. ET
Get Ready To Explore the Latest Coronary Surgery Research and Techniques
Event dates
Jun 7–8, 2024
Location
Fontainebleau Miami Beach
An experiential foundation and hands-on practice in basic cardiothoracic operating skills for first-year residents.
Event dates
Aug 22–25, 2024
Location
Chicago, IL
Discussions on valuable research and important clinical findings with the goal of improving data collection and patient outcomes.
Event dates
Sep 11–13, 2024
Location
Nashville, TN
Event dates
Sep 20–21, 2024
Location
Chicago, IL
Event dates
Oct 25–26, 2024
Location
Philadelphia, PA
The latest coding and reimbursement updates affecting cardiothoracic surgical practices.
Event dates
Feb 10–11, 2023
Location
Virtual
Event dates
Jan 21–23, 2023
Location
San Diego, California
Event dates
Dec 1–3, 2022
Location
Cartagena, Colombia

The management of stage IIIA non-small cell lung cancer (NSCLC) is evolving in the era of immune checkpoint inhibitor therapy. In the past, there has been a great deal of controversy regarding the optimal management of patients with N2 nodal metastasis at the time of diagnosis of NSCLC. There are some new questions to address when considering the results of the Checkmate 816 and the NADIM II clinical trials which demonstrated improved disease-free survival and overall survival with neoadjuvant combined chemotherapy and Nivolumab.

Date
Duration
58 min.

Recent approvals by the U.S. Food and Drug Administration (FDA) have made available two new technologies for treating aortic disease. The GORE® TAG® Thoracic Branch Endoprosthesis (TBE) is single-branch aortic stent graft that provides an off-the-shelf solution for patients that need zone II aortic coverage and obviates the need for prior left subclavian revascularization. The Thoraflex Hybrid Frozen Elephant Trunk (FET) device is a pre-mated surgical graft and an aortic stent graft to facilitate single-stage treatment of arch and proximal descending aortic pathologies.

Date
Duration
1 hr. 7 min.